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In Saccharomyces cerevisiae the UPF1 protein is required for nonsense-mediated mRNA
decay, the accelerated turnover of mRNAs containing a nonsense mutation. Several lines
of evidence suggest that translation plays an important role in the mechanism of
nonsense mRNA decay, including a previous report that nonsense mRNAs assemble in
polyribosomes. In this study we show that UPF1 and ribosomal protein Li co-localize in
the cytoplasm and that UPF1 co-sediments with polyribosomes. To detect UPF1, three
copies of the influenza hemagglutinin epitope were placed at the C-terminus. The tagged
protein, UPF1-3EP, retains 86% (+ 5%) of function. Using immunological detection, we
found that UPF1-3EP is primarily cytoplasmic and was not detected either in the nucleus
or in the mitochondrion. UPF1-3EP and Li co-distributed with polyribosomes fractionated in a 7-47% sucrose gradient. The sucrose sedimentation profiles for UPF1-3EP and
Li exhibited similar changes using three different sets of conditions that altered the
polyribosome profile. When polyribosomes were disaggregated, UPF1-3EP and Li accumulated in fractions coincident with 80S ribosomal particles. These results suggest that
UPF1-3EP associates with polyribosomes. L3 and S3 mRNAs, which code for ribosomal
proteins of the 60S and 40S ribosomal subunits, respectively, were on average about
100-fold more abundant than UPF1 mRNA. Assuming that translation rates for L3, S3,
and UPF1 mRNA are similar, this result suggests that there are far fewer UPF1 molecules
than ribosomes per cell. Constraints imposed by the low UPF1 abundance on the
functional relationships between UPF1, polyribosomes, and nonsense mRNA turnover
are discussed.
INTRODUCTION
Messenger RNA abundance is determined by the relative rates of mRNA synthesis and decay. Regulation
often occurs at both levels to achieve the flexibility
needed for a rapid cellular response to environmental
changes or developmental programs (Sachs, 1993). Although much more is currently known about transcriptional regulatory mechanisms, the general feat Present address: McArdle Laboratory for Cancer Research, University of Wisconsin, Madison, WI 53706.
§ Corresponding author: Laboratory of Molecular Biology, R.M.
Bock Building, University of Wisconsin, 1525 Linden Drive, Madison, WI 53706.
i 1995 by The American Society for Cell Biology

tures of mRNA decay pathways are beginning to
emerge.
Recently, several genes have been identified in Saccharomyces cerevisiae and Caenorhabditis elegans whose
products participate in one or more pathways leading
to accelerated decay of mRNAs that terminate translation prematurely because of a nonsense mutation
(Leeds et al., 1991, 1992; Pulak and Anderson, 1993).
This kind of mRNA decay process, referred to as
"nonsense-mediated mRNA decay" (Peltz and Jacobson, 1993), may serve a useful purpose by degrading
mRNAs that contain a premature block in translation
due to errors in transcription and processing (He et al.,
1993; Pulak and Anderson, 1993). Such a system
611
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would prevent the accumulation of potentially deleterious truncated proteins. In addition, these pathways
may also control the steady state levels of some specific mRNAs as suggested by Leeds et al. (1991).
Nonsense mRNAs appear to be targeted for accelerated decay due to premature translational termination, implying that mRNA decay pathways of this
type act in concert with translation. Functional coupling of translation and nonsense mRNA decay is
further suggested by the observation that efficient
tRNA nonsense suppressors restore stability to nonsense mRNAs (Losson and Lacroute, 1979; Gozalbo
and Holmann, 1990; Belgrader et al., 1993). Hairpin
structures inserted in the 5'-untranslated region of
mRNA that reduce the rate of translational initiation
restore stability to nonsense mRNA (Belgrader et al.,
1994). Also, nonsense mRNAs that are subject to accelerated decay are found to be associated with polyribosomes that are actively engaged in translation
(Leeds et al., 1991).
In S. cerevisiae, studies of the UPF1 and UPF3 genes
have led to new insights into the mechanism of nonsense mRNA decay (Leeds et al., 1991, 1992). In strains
lacking a functional UPF1 or UPF3 product, the decay
rate of nonsense mRNA is restored to a level comparable to the corresponding wild-type mRNA, but the
half-life of the wild-type mRNA remains unaltered.
Unlike tRNA suppressors that were shown to stabilize
nonsense mRNAs by promoting translational readthrough of a premature stop codon (Losson and Lacroute, 1979), loss of UPF1 function does not appear to
enhance read-through (Leeds et al., 1991). These results suggest that despite the dependence of nonsense
mRNA decay on efficient premature translational termination, the UPF1 product does not stimulate decay
merely by ensuring efficient termination. Considering
that upfl - cells are also hypersensitive to cycloheximide, an inhibitor of translational elongation, it seems
likely that one or more of the UPF gene products will
be found to interact directly with ribosomes actively
engaged in translation.
Although nonsense mRNA decay may be triggered
in physical proximity with cytoplasmic ribosomes, recent studies in mammals suggest that a complex
mechanism is possible. Cheng and Maquat (1993)
measured the accumulation of human TPI mRNA and
found that nonsense mutations reduced the accumulation of both nuclear and cytoplasmic mRNA pools. If
decay occurred in the cytoplasm, one would have
expected a decrease in the cytoplasmic mRNA pool
only. This result could not be explained by any observed differences in rates of transcription or processing of nuclear pre-mRNA or in the rate of cytoplasmic
mRNA decay. The results could, however, be explained if the decay pathway is nuclear-associated.
For example, nonsense mutations that are utilized
during translation in the cytoplasm could trigger de612

cay during transport of the mRNA from the nucleus to
the cytoplasm (Belgrader et al., 1993, 1994). This implies that nuclear export and translation may be spacially and temporally coupled, a possibility that remains to be verified experimentally.
One way to see where nonsense mRNA degradation
takes place is to determine where gene products that
catalyze steps in the pathway localize. At present
there is no definitive proof that any of the UPF gene
products directly catalyze steps in the pathway. However, we regard UPF1 as a good candidate for direct
participation, based on the phenotypes of both dominant and recessive alleles of UPF1, and on the presence of structural motifs in the amino acid sequence
that suggest a potential for interaction with RNA. We
have addressed the question of where UPF1 localizes
by developing an immunological detection system for
UPF1 based on epitope tagging. Our evidence suggests that yeast UPF1 is present in low abundance
throughout the cytoplasm, but is below the limits of
cytochemical detection in the nucleus and the mitochondrion. UPF1 has sedimentation properties in
sucrose gradients suggesting an association with polyribosomes. The possible functional relationships between the association of UPF1 with polyribosomes
and the possible roles of LTPF1 and polyribosomes in
nonsense mRNA decay are discussed.
MATERIALS AND METHODS
Strains and Genetic Methods
The S. cerevisiae strains used in this study are described in Table 1.
Strains were constructed using standard yeast genetic techniques
(Rose et al., 1990). Media for growth and maintenance of yeast was
described by Gaber and Culbertson (1982). Yeast transformations
were performed using the method of Ito et al. (1983) as described by
Ausubel et al. (1993). Escherichia coli strain DH5a was used for
preparation of plasmid DNAs. Methods for growth, maintenance,
and transformation of bacteria are described by Sambrook et al.
(1989).

Nucleic Acid Methods
Plasmid DNA was prepared from E. coli by the method of Bimboim
and Doly (1979) as described by Sambrook et al. (1989). DNA sequence analysis was performed by the method of Sanger et al. (1977)
using the Sequenase 2.0 kit (United States Biochemical, Cleveland,
OH). RNA prepared for Northern analysis was isolated by hot
phenol extraction as described by Leeds et al. (1991). RNA/DNA
hybridizations were carried out by Northern blotting. Total RNA
was resolved on 1.0% agarose/formaldehyde gels and blotted onto
GeneScreen Plus membranes using the capillary blot protocol recommended by the manufacturer (DuPont, NEN Products, Boston,
MA). Hybridization conditions were as described by Klessig and
Berry (1983), except that 1.0% sarkosyl was used in the prehybridization and hybridization buffers. DNA probes were prepared from
restriction fragments resolved on low-melting point agarose gels
and oligolabelled by the method of Feinberg and Vogelstein (1983)
using an oligolabelling kit (Pharmacia Biotech, Piscataway, NJ) and
[a32PJdCTP (3000Ci/mmol; Amersham, Arlington Heights, IL).
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Construction of UPF1-3EP
The influenza virus hemagglutinin (HA) epitope was placed at the
C-terminus of UPF1 by in vitro construction of an allele designated
UPF1-3EP. A 114-bp NotI fragment coding for three copies of the
nine-amino acid long HA epitope was isolated after NotI digestion
of plasmid GTEPI (Roof et al., 1992). The NotI fragment was placed
at the 3' end of UPF1 by first creating a NotI site between the last
sense codon and the termination codon. To accomplish this, a
1473-bp SspI fragment with end points inside the UPF1 coding
region was deleted from a pUC19 sub-clone that carried the full
length UPF1 gene (designated pUC19UPFlASspI). Primers 5'-CCC
GCG GCC GCC TAT TCC CAA ATT GCT GAA GTC-3' and 5'-CCC
GCG GCC GCT AAT TCG GTG AAC CCT GTT AA-3' were used in
polymerase chain reaction (Ausubel et al., 1993) to create the NotI
site between the last sense codon and the stop codon of UPF1ASspI.
Polymerase chain reaction products were analyzed by DNA sequence analysis. The NotI fragment coding for the HA epitope was
subcloned into the newly introduced NotI site of UPF1ASspI by
standard subcloning procedures. A NruI-BamHI fragment of UPF1
DNA containing the NotI insert was used to replace the wild-type
NruI-BamHI fragment in the UPFI gene carried on plasmid pRS316,
resulting in plasmid pRS316UPF1-3EP. Subsequently, an EcoRIBamHI fragment from pRS316UPF1-3EP containing UPF1-3EP was
subcloned into pRS314 and pRS315, resulting in plasmids
pRS314UPF1-3EP and pRS315UPF1-3EP. pRS314, pRS315, and
pRS316 are centromeric plasmids carrying the yeast TRP1, LEU2,
and URA3 selectable markers, respectively (Sikorski and Hieter,

1989).

Protein Methods
Total protein extracts from yeast were prepared as follows: cultures
were grown in 40 ml of -Ura medium at 30°C to a final OD6. of 0.6.
Cells were pelleted at 8000 x g for 10 min and then washed in 10 ml
of lysis buffer (5 mM EDTA, 250 mM NaCl, 0.1% Nonidet P-40, 50
mM Tris HCl, pH 7.4, 4°C). The cell pellet was resuspended in 0.8 ml
of lysis buffer plus protease inhibitors (0.1 mM phenylmethylsulfonyl fluoride (PMSF), 1 ,ug/ml aprotinin, 1 ,ug/ml pepstatin A, 1
,tg/ml chymotrypsin, 1 ,ug/ml leupeptin, and 1 ,g/ml antipain).
The cell slurry was divided between two 1.5-ml Eppendorf centrifuge tubes, and lysed with ice cold, acid-washed glass beads by
continuous vortexing for 3 min at 4°C. The supernatant was recovered and then cleared by centrifugation for 20 min at 4°C. The
amount of protein in the cell lysates was quantitated using a BCA
protein quantitation kit (Pierce, Rockford, IL). Twenty micrograms
of protein was used for sodium dodecyl sulfate-polyacrylamide gel

electrophoresis (SDS-PAGE).
For Western blotting, SDS-PAGE and electrophoretic transfer to
nitrocellulose were done using a Bio-Rad Mini-Protean apparatus
(Bio-Rad, Hercules, CA) as described by Bollag and Edelstein (1991).
Western blotting was done using the ECL Western blotting detection system (Amersham) or as described by Bollag and Edelstein
(1991) with modifications. Nitrocellulose blots were decorated with
12CA5 (Berkeley Antibody Company, Richmond, CA), anti-Li (provided by J. Woolford), anti-RNA1 (provided by A. Hopper), and
anti-Hsp6O and anti-hexokinase (provided by G. Schatz) primary
antibodies. Secondary antibodies were either a goat anti-mouse IgG
antibody-alkaline phosphatase (calf intestine) conjugate or a goat
anti-rabbit IgG antibody-alkaline phosphatase (calf intestine) conjugate (Boeringer Mannheim Biochemicals, Indianapolis, IN). Western
blots were washed twice in TBST (50 mM Tris HCl, pH 7.5, 200 mM
NaCl, and 0.05% Tween 20), twice in BBST (0.1 M boric acid, 25 mM
sodium borate, 1 M sodium chloride, and 0.1% Tween 20) and twice
in TBST after incubation with the primary antibody. After incubation with the secondary antibody, blots were washed as previously
described except that the final two washes were in TBS (50 mM
Tris-HCl, pH 7.5, 200 mM NaCl).
Competition experiments were performed as described above,
except that HA competitor peptide (YPYDVPDYA; Multiple Peptide

Systems, San Diego, CA) containing the epitope recognized by the
12CA5 antibodies was added to the primary antibody-binding
buffer.

Indirect Immunofluorescent Microscopy
Ten milliliter cultures of yeast were grown to mid-log phase (OD600
= 0.4-0.7) in medium to select for the presence of plasmids carrying
the UPF1-3EP gene. Next, 1.4 ml of 37% formaldehyde was added
and the culture was incubated at 37°C for 5 min with gentle shaking.
The culture was then allowed to sit at room temperature for 1 h. The
cells were pelleted for 2 min at 300 x g and then washed three times
in 3 ml of buffer 1 (1.2 M sorbitol, 0.1 M potassium phosphate, pH
6.5, 1% 13-mercaptoethanol). Cells were resuspended in 0.5 ml of
buffer 1 and 50 U of lyticase was added followed by incubation for
9 min at 30°C with gentle shaking. The cells were pelleted and
washed twice with 3 ml of buffer 2 (1.2 M sorbitol, 0.1 M potassium
phosphate, pH 6.5). Cells were resuspended in buffer 2 to approximately A6o0 = 5.0/ml. Cells (60 ,l) were spotted onto slides pretreated with 1% polyethyleneimine. The cells were allowed to settle
for 30 min and then the slides were rinsed twice in phosphatebuffered saline (PBS). The slides were then immersed in methanol
(pre-chilled to -20°C) for 6 min followed by immersion in acetone
(chilled to -20'C) for 30 s. Slides were air dried. Cells were blocked
with 30 ,ul of blocking buffer (1% bovine serum albumin and 0.05%
Nonidet P-40 in PBS) for 15 min at room temperature. Thirty microliters of PBS containing the primary antibodies was added and
the slides were incubated overnight at room temperature. Slides
were washed twice in 0.5% Nonidet P-40, PBS and then three times
in PBS. The cells were blocked again as described above, followed
by the addition of 30 ,lI of PBS containing the secondary antibodies.
The slides were incubated for 1 h at room temperature and then
washed as previously described. The DNA was stained with 4,6diamidino-2-phenylindole (DAPI) by adding 30 ,ul of 1 ,Lg/ml
DAPI, incubating the slides for 5 min at room temperature, and then
rinsing twice in PBS. The slides were allowed to air dry. Once dry,
the cells were mounted in 0.1% phenylenediamine. Slides were
viewed using a Fluor 10OX oil immersion lens on a Nikon optiphot
biological microscope adapted for fluorescence microscopy with a
microflex UFX-IIA photomicrographic attachment (Nikon, Garden
City, NY), and a Zeiss/IM35 (Thornwood, NY) equipped with a
Bio-Rad MRC600 Lasersharp Confocal system.
UPF1-3EP was detected with the 12CA5 antibodies obtained from
the Berkeley Antibody Company. SEN1::P3gal was detected by polyclonal antibodies against the ,3gal portion of the fusion and were
obtained from S. Blair. KAR2, LI, and MAS2 antibodies were obtained from M. Rose, J. Woolford, and E. Craig, respectively. Secondary antibodies were either a goat anti-mouse IgG fluorescein
conjugate or a goat anti-rabbit IgG-L-rhodamine conjugate (Boehringer Mannheim Biochemicals).

Cell Fractionation
Cells were fractionated and a crude ribosome pellet was prepared
using the method of Grant et al. (1974) with modifications from
Sachs and Davis (1989). Part of the cell lysate (150 ,ul) was reserved
as a total cellular extract. The remaining 1 ml cell lysate was centrifuged at 5,000 x g for 5 min. The supernatant (cytosol-enriched
fraction) was transferred to a fresh tube and the pellet was resuspended in 1 ml of Laemmli buffer supplemented with 4.5 M urea.
The ribosomes were pelleted from 600 ,ll aliquots of the cytosolenriched fraction by centrifugation at 160,000 x g for 90 min. The
supernatant was transferred to a fresh Eppendorf tube, and the
pellet was resuspended in 600 pl of Laemmli buffer supplemented
with 4.5 M urea.
Cells were fractionated into mitochondrial and post-mitochondrial fractions essentially as described by Herbert et al. (1988), except
that crude mitochondria were washed four times in the presence of
1 mM PMSF followed by two washes in the absence of PMSF.
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Mitochondria were treated with 0.2 mg/ml proteinase K for 30 min
on ice. Where indicated, mitochondria were solubilized by addition
of Triton X-100 to 0.5%. Proteinase K digestion was terminated by
adding PMSF to 1 mM.

Polyribosome Analysis
Polyribosomes were prepared and fractionated as described by
Deshmukh et al. (1993) with the following modifications. Washed
cells were suspended in 0.8 ,ul of lysis buffer. Where indicated the
cycloheximide was omitted from the lysis buffer. For RNase disruption of polyribosomes, 5 ,ul of a 10 mg/ml RNase A was added to
200 ,ul polyribosomes isolated in the absence of DEPC with or
without the addition of 50 ,ug/ml cycloheximide and incubated for
15 min on ice before loading onto sucrose gradients. Growth conditions were altered by shifting cells grown in -Trp medium into
YEPD at an OD6,0 of 0.1. Cell were harvested at an OD600 of 0.4.
Plasmid loss was monitored by plating onto YEPD at the time cells
were harvested and then replica plating onto -Trp plates. Aliquots
of 20-25 A260 units of cell lysate were loaded onto 12 ml, 7-47%
sucrose gradients and subjected to centrifugation at 39,000 rpm for
2.5 h in a SW41 rotor (Beckman Instruments, Fullerton, CA). The
OD254 profile of the gradient was determined with an ISCO UA-6
detector (Lincoln, NE) equipped with a density gradient flow cell.
Fractions (0.5 ml) were collected using an ISCO Foxy Jr. fraction
collector. The proteins in the fractions were acetone precipitated,
and then resuspended in 10 ,ul of Laemmli buffer supplemented
with 4.5 M urea. Samples were fractionated by SDS-PAGE and
transferred to membranes for Western blotting using the ECL Western blotting detection system (Amersham). The bands on autoradiographs of the Western blots were quantitated using a Model 300A
computing densitometer (Molecular Dynamics, Sunnyvale, CA).
Hyperfilm ECL (Amersham) was pre-flashed before autoradiography and only bands within the linear dynamic range were quantitated. The density of the bands on autoradiographs and the concentration of protein in the bands is not directly proportional because
the emission of light from ECL Western blots is nonlinear. As a
consequence of this, the peak accumulation of protein is underestimated using this technique.

RESULTS
The aim of this study was to determine the intracellular localization of UPF1. Using immunological
detection, we determined localization by three methods: indirect immunofluorescence, cell fractionation,
and distribution relative to polyribosomes fractionated in a sucrose gradient. To detect UPF1 in these
experiments, the wild-type gene was modified by

placing a DNA sequence immediately 5' to the normal
termination codon that codes for three tandem copies
of the 12CA5 influenza virus HA epitope (see MATERIALS AND METHODS). The modified gene, designated UPF1-3EP, was subcloned into centromeric
plasmids and introduced into strains PLY38, BJ2168,
and PLY102 (Table 1). PLY38 and PLY102 both lack a
functional UPF1 gene. BJ2168 carries a wild-type UPF1
gene. The experiments described below were performed using these strains.
A C-Terminal Epitope-tagged UPF1 Product Is
Functional In Vivo

The ability of UPF1-3EP to provide wild-type UPF1
function in vivo was tested using a frameshift allosuppression assay described previously in which the rate
of growth on medium lacking histidine is sensitive to
the turnover rate of his4-38 mRNA (Culbertson et al.,
1980; Leeds et al., 1991). Strains wild type for the UPF
(up frameshift) genes and carrying both his4-38 and
SUF1-1 have a His' phenotype at 30°C, but these cells
remain His- at 37°C. Mutations in UPF confer a His'
phenotype at 37°C through restabilization of his4-38
mRNA. Using this assay (Figure 1A), we found that
the growth of strain PLY38[pRS316UPF1-3EPI at 37°C
was somewhat faster but very similar to strain
PLY38[pRS316UPF1I. However, strain PLY38[pRS3161, which lacks both UPF1 and UPF1-3EP,
grew rapidly to confluency at 37°C. These growth tests
indicate that UPF1-3EP confers nearly complete
complementation of the loss of wild-type UPF1 function.
The function of UPF1-3EP was compared with
UPF1 using quantitative Northern blotting to determine the effect of each gene on his4-38 mRNA accumulation. The relative levels of his4-38 mRNA accumulation in strain PLY38 transformed separately with
pRS316, pRS316UPF1, and pRS316UPF1-3EP were 1.0,
0.47 (± 0.03), and 0.55 (± 0.06), respectively. Thus,
UPF1-3EP reduced his4-38 mRNA accumulation 86%
(+ 5%) as well as the wild-type UPF1 protein. Because

Table 1. Yeast strains
Strain

Genotype

Source

PLY22
PLY38
PLY102
PLY142
BJ2168
CW04
CNA

MATa ura3-52 his4-38 SUFl-1 metl4
MATa upfl-2a his4-38 SUF1-l ura3-52
MATa upfl-Al ura3-52 trpl-7 leu2-3,-112
MATa his4-38 SUF1-l upfl-Al ura3-52 trpl-Al leu2-1
MATa ura3-52 leu2 trpl prcl-407 prbl-1122 pep4-3 gal2
MATa his3-11 leu2-3,112 ade2-1 ura3-1 trpl-1 canl-100 UPF1 (rho+, mit+)
MATa his3-11 leu2-3,112 ade2-1 ura3-1 trpl-1 canl-100 upfl-A3 (rho+, mit+)

This study
This study
Leeds et al., 1991
This study
E. Jones
Altamura et al., 1994
Altamura et al., 1994

aThe mutation in upfl-2 is a single nucleotide change at nucleotide +615 that changes a UGG Trp codon to a UGA nonsense codon. This allele
of UPF1 has a phenotype that is indistinguishable from a null allele of UPFI (Leeds et al., 1992).
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100.671.2Figure 1. (A) In vivo complementation. Growth tests were performed to assess the ability of UPF1-3EP to compensate for loss of
wild-type UPF1 function. Strains carrying the suppressible frameshift mutation his4-38 (Donahue et al., 1981), the tRNA frameshift
suppressor SUF1-1 (Mendenhall et al., 1987), and a wild-type UPF1
gene fail to grow at 37°C on -histidine medium due to destabilization of his4-38 mRNA (Leeds et al., 1991). Equivalent strains
carrying a UPF1 loss-of-function mutation grow at 37'C on -histidine medium due to re-stabilization of his4-38 mRNA (Culbertson
et al., 1980; Leeds et al., 1991). Strain PLY38, which carries the upfl-2
allele (Table 1), was separately transformed with three centromeric
plasmids carrying the yeast URA3 gene: pRS316 (no UPF1 gene),
pRS316UPF1 (wild-type UPF1 gene), and pRS316UPF1-3EP
(epitope-tagged UPF1 gene). Growth of the resulting transformants
was tested by plating 100, 10-1, 10-2, and 10-3 serial dilutions of
overnight cultures on -Ura and -Ura -His medium at 30'C and
37'C. Rows 1 and 4 show the extent of growth of PLY38[pRS316].
Rows 2 and 5 show the extent of growth of PLY38[pRS316UPF1].
Rows 3 and 6 show the extent of growth of
PLY38[pRS316UPF1-3EP]. Identical results were obtained using
transformants of strain PLY142 carrying upfl-Al. (B) Immuno-detection of UPF1-3EP on Western blots using 12CA5 antibodies. The
blots were prepared using total protein extracts from strain BJ2168
(Table 1) transformed with plasmid pRS316 (lane 2) and
pRS316UPF1-3EP (lane 3). Pre-stained molecular weight markers
were loaded in lane 1.

his4-38 mRNA accumulation is proportional to halflife in PLY38 transformants (Leeds et al., 1991), the
levels of accumulation reflect how well UPF1-3EP
promotes nonsense mRNA decay. Furthermore, the
UPF1-3EP phenotype is recessive to wild type, indicating that the modestly reduced function of
UPF1-3EP could result from a reduction in the
Vol. 6, May 1995

amount of UPF1 protein or a partial loss of function.
Based on these results, the behavior of UPF1-3EP is
expected to resemble that of the wild-type UPF1
protein and is therefore suitable for localization
studies.
The product of the UPF1-3EP gene was detected as
a single band with an approximate molecular weight
of 113 k on a Western blot of protein from strain
BJ2168[pRS316UPF1-3EPI probed with 12CA5 antibodies (Figure 1B). The estimated molecular weight of
this band based on its migration in SDS-polyacrylamide gels relative to molecular weight standards
agrees well with the molecular weight for UPF1-3EP
predicted from the DNA sequence. This band was not
detected in protein derived from strain BJ2168[pRS316], which lacks the UPF1-3EP gene. These results suggest that the observed band is the product of
the UPF1-3EP gene. No other bands are detectable
using the Western blotting conditions described in
MATERIALS AND METHODS. To further substantiate these conclusions, a peptide competition experiment was performed. Increasing concentrations of free
peptide containing the 12CA5 epitope diminished the
113-k signal on Western blots. Therefore, the observed
band results from the recognition of UPF1-3EP by
12CA5 antibodies (our unpublished observations).
As a final test of the experimental system, we performed indirect immunofluorescent microscopy using
12CA5 antibodies. Strain PLY102[pRS314UPF1-3EPI
gave a visible fluorescent signal, whereas PLY102[pRS316] did not (our unpublished observations). This
result indicates that background fluorescence was sufficiently low to allow cells expressing UPF1-3EP to be
used to localize the protein.
UPF1-3EP Is Cytoplasmic
UPF1-3EP was localized by indirect immunofluorescence in cells double-labeled with antibodies against
UPF1-3EP and Li, a SEN1::,Bgal fusion, KAR2, or
MAS2. Li, a component of the 60S ribosomal subunit
(Deshmukh et al., 1993), is located primarily in the
cytoplasmic ribosomes. A small amount of Li is also
found in the nucleolus where ribosomal subunits are
assembled. SEN1::P3gal localizes to the nucleus (Ursic,
DeMarini, and Culbertson, unpublished data; DeMarini et al., 1992). KAR2 localizes to the endoplasmic
reticulum (ER) (Rose et al., 1989). Because the ER is
contiguous with the nuclear membrane in yeast, fluorescence due to KAR2 often forms a ring that marks
the boundary between the cytoplasm and the nucleus
(Rose et al., 1989). Eighty percent of the cells stained
with KAR2 antibodies had a ring marking the boundary between the cytoplasm and the nucleus (our unpublished observations). MAS2 is found in the mitochondrial matrix (Jensen and Yaffe, 1988).
615
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Figure 2 shows a comparison of representative
cells stained with antibodies against Li, SEN1::43gal,
KAR2, MAS2, and UPF1-3EP. DNA was visualized
by staining with DAPI. The staining pattern with
12CA5 antibodies that recognize UPF1-3EP is characteristic of a protein localized to the cytoplasm. The
region with the least intense 12CA5 staining corresponds to the region of intense DAPI staining. DAPI
marks the location of chromosomal DNA. Staining
with anti-f3gal and anti-KAR2 antibodies shows the
location of the nucleoplasm and the nuclear/cytoplasmic boundary, respectively. These results indicate that UPF1-3EP is primarily localized in the
cytoplasm. From these experiments, UPF1-3EP does
not co-localize exclusively with the mitochondrial
protein MAS2. The possibility that some UPF1-3EP
might localize to the mitochondrion was addressed
in subsequent experiments using confocal microscopy and fractionation.
Confocal microscopy was used to further resolve
any potential overlap in the distribution of UPF1-3EP

with LI, SEN1::,gal, KAR2, and MAS2 (Figure 3).
12CA5 antibodies were used to visualize UPF1-3EP
using fluorescein-conjugated secondary antibodies
(Figure 3, left column). These cells appear to stain
mostly green, but with some regions where no staining is visible. To determine if the unstained regions
correspond to the nuclei, we examined overlays of
images showing UPF1-3EP staining with images of
rhodamine-stained SENl::4gal or KAR2 (red) (Figure
3, B and C). Any overlap in staining pattern appears as
yellow. Very little overlap in the staining pattern of
UPF1-3EP and SEN1::3gal or KAR2 was observed,
indicating that there is little or no detectable
UPF1-3EP in the nucleus. Also, there was very little
overlap in the staining pattern of UPF1-3EP and
MAS2, the mitochondrial matrix protein (Figure 3D).
In contrast, an intense yellow color indicates significant overlap in distribution between UPF1-3EP and
ribosomal protein LI (Figure 3A). We cannot rule out
the possibility that there may be small amounts of
UPF1-3EP in the nucleus, ER, or mitochondria, but if

Figure 2. UPFl-3EP is localized in the cytoplasm. Strain PLY102 (Table 1) was transformed with centromeric plasmid pRS314UPFl-3EP.
Cells were stained with DAPI (bottom row: A3, B3, C3, and D3) and with 12CA5 antibodies that recognize UPFl-3EP (top row: Al, Bi, Cl,
and Dl). The middle row shows cells stained with antibodies that recognize Li (A2), SENl::I3gal (B2), KAR2 (C2), and MAS2 (D2). LI is
primarily localized in the cytoplasm, SEN::,3gal in the nucleus, KAR2 in the endoplasmic reticulum, and MAS2 in the mitochondrion (Jensen
and Yaffe, 1988; Rose et al., 1989; Deshmukh et al., 1993; Ursic, DeMarini, and Culbertson, unpublished data). The SEN1::f3gal fusion, which
is expressed from a GALl promoter on a 2 ,u plasmid, was induced by pre-growth in raffinose followed by growth in galactose-containing
medium. Bar, 5 mm.
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Figure 3. The distribution of UPF1-3EP overlaps with ribosomal protein LI. Strain PLY102 (Table 1), was transformed with the centromeric
plasmid pRS314UPF1-3EP. Cells were stained with 12CA5 antibodies that recognize UPF1-3EP using fluorescein-conjugated secondary
antibodies (first column, green) and with antibodies that recognize LI (A2), (3-gal (B2), KAR2 (C2), or MAS2 (D2) using rhodamine-conjugated
secondary antibodies (second column, red). Staining was visualized by confocal microscopy. Single images from the first and second columns
were overlaid to determine the extent of co-distribution [UPF1-3EP and LI (A3), SEN1::,gal (B3), KAR2 (C3), and MAS2 (D3)]. The regions
of co-localization appear as yellow. Bar, 2 mm.

present in these compartments it must be at concentrations below the level of detection using this approach.

UPF1-3EP Fails to Accumulate in Mitochondria
The UPEl gene isolated by Leeds et al. (1992) on the
basis of allo-frameshift suppression (Leeds et al., 1991)
was also identified as NAM7 by Altamura et al. (1992)
in a screen for multi-copy suppressors of a mitochondrial splicing-deficient mutation (Ben Asher et al.,
1989). Although UPF1 is not essential for growth in
Vol. 6, May 1995

glucose-containing medium (Leeds et al., 1992), loss of
UPF1 function causes respiratory impairment and
slow growth in lactate-containing medium (Altamura
et al., 1992) (Figure 4A). These results suggest a potential function for UPF1 in the mitochondrion. To investigate this observation further, cell lysates were fractionated using a method that separates the
mitochondria from the cytoplasm (see MATERIALS
AND METHODS). The fractions were examined by
Western blotting using antibodies that recognize
UPF1-3EP, the mitochondrial matrix protein Hsp6O,
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Figure 4. UPF1-3EP complements respiratory deficiency, but the UPF1-3EP protein fails to accumulate in mitochondria. Strains
carrying a upfl::URA3 null allele fail to grow on medium containing lactate as the sole carbon source at 18°C (Altamura et al., 1992).
We tested whether UPF1-3EP can suppress the growth defect caused by a upfl::URA3 null allele in strain CNA (Table 1), and whether
any UPF1-3EP can be detected in the mitochondrion. (A) Transformants of strain CNA (Table 1) carrying different UPF1 alleles on
centromeric plamids were grown on medium containing lactate as the sole carbon source for 12 days at 18°C, as follows: (1) CNA
[pRS315UPF1], (2) CNA [pRS315UPF1-3EP], (3) CNA [pRS3151, which does not carry any UPF1 sequences, and (4) CW04, an isogenic
wild-type strain carrying the UPF1 gene. The results indicate that UPF1-3EP suppresses the growth defect conferred by the upfl::URA3
null allele, and it supports growth on lactate medium in a manner similar to UPF1. (B and C) Mitochondrial and cytoplasmic fractions
were prepared from strain PLY102 (Table 1) transformed with pRS314UPF1-3EP (see MATERIALS AND METHODS). Fractions were
analyzed by SDS-PAGE and Western blotting using antibodies that recognize UPF1-3EP, the mitochondrial matrix protein Hsp6O, and
the cytoplasmic protein hexokinase. Lanes in panel B were loaded as follows: TOT, 150 ,ug of total extract; MIT, 30 ,tg of the
mitochondrial fraction; CYT, 113 ,ug of the post-mitochondrial fraction. Lanes in panel C were loaded with 100 ,ug of the mitochondrial
fraction treated as follows: Lane 1, untreated; lane 2, addition of 0.2 mg/ml proteinase K; lane 3, solubilization in 0.5% Triton X-100
followed by the addition of 0.2 mg/ml proteinase K.

and the cytoplasmic protein Hexokinase (Figure 4B).
Most of the detectable Hsp6O and a small amount of
Hexokinase were found in the mitochondrial fraction,
whereas no Hsp6O and the majority of Hexokinase
were found in the cytoplasmic fraction. The fractionation of UPF1-3EP resembled that of Hexokinase.
Mitochondria were treated with proteinase K to
determine whether the small amount of UPF1-3EP
in the mitochondrial fraction is located inside or
outside of the mitochondrion. After proteinase K
treatment of the mitochondrial fraction, UPF1-3EP
was no longer detectable, whereas Hsp6O was
readily detected (Figure 4C). This shows that
UPF1-3EP is outside the mitochondrion. The lack of
growth on lactate-containing medium, which is indicative of respiratory impairment, probably is an
indirect consequence of UPF1 function outside the
mitochondrion.
UPF1-3EP Is Associated with Polyribosomes
Cell fractionation experiments indicated that a significant portion of the detectable UPF1-3EP co-fraction618

ates with LI, and hence, with ribosomes (our unpub-

lished observations). To determine whether UPF1-3EP
is specifically associated with ribosomes, its distribution was compared with the distribution of Li in
polyribosomes fractionated in a 7-47% sucrose gradient (see MATERIALS AND METHODS and Figure 5).
Protein extracts were prepared from cells grown in
-Trp synthetic medium to select for the presence of
the plasmid carrying UPF1-3EP. To arrest translational elongation, 50 ,ug/ml cycloheximide was added
to the growth medium immediately before harvesting
the cells. Cycloheximide was also included at the same
concentration in the lysis buffer to prevent ribosome
runoff during extract preparation. The extracts were
resolved into 40S and 60S ribosomal subunits, 80S
ribosomal particles, and polyribosomes (Figure 5A).
Western blots prepared from fractions recovered from
the sucrose gradients were sequentially labeled with
antibodies to detect UPF1-3EP and Li. Autoradiographs of the blots were quantitated using the ECL
Western blotting detection system (Amersham). Light
emission by ECL is nonlinear, consequently the peak
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accumulation of proteins by this technique is underestimated (see MATERIALS AND METHODS). Using
these conditions, approximately 80% of UPF1-3EP
was detected in fractions 8-24+P (P = pellet). These
fractions contain ribosomal subunits, 80S particles and
polyribosomes. About 20% was detected in fractions
1-7 from the top of the gradient where monomeric
proteins, smaller aggregates, and complexes are expected to migrate. Virtually all of the detectable Li, a
component of the 60S ribosomal subunit, was found in
fractions 8-24+P. These fractions include the 60S ribosomal subunits, the 80S particles and the polyribosomes. In the fractions 8-24+P that contain the 80S
ribosomal particle and the polyribosomes, UPF1-3EP
and Li have a very similar distribution. These results
indicate that a significant proportion of UPF1-3EP is
part of a high molecular weight aggregate or complex
that co-distributes with polyribosomes.
Strains carrying a upfl - null mutation are hypersensitive to cycloheximide (Leeds et al., 1992). To test the
possibility that the addition of cycloheximide to the
growth medium and the lysis buffer affects the sedimentation profile of UPF1-3EP, extracts were prepared using a range of cycloheximide concentrations.
Using 25-50 ,ug/ml cycloheximide, the A254 profile
and the distribution of UPF1-3EP across the sucrose
gradient resembled the profile and distribution shown
in Figure 5A. In the presence of 100-200 ,tg/ml cycloheximide, the A254 profiles were unaltered but the
amount of UPF1-3EP distributed across the gradient
appeared to be reduced (our unpublished observations). These results indicate that 50 ,ug/ml cycloheximide can be used in the preparation of polyribosomes
without significantly affecting the distribution of
UPF1-3EP.
Conditions known to affect the distribution of
polyribosomes on sucrose gradients also affected the
distribution of UPF1-3EP and Li. In Figure 5B, cycloheximide was omitted during polyribosome
preparation. The omission of cycloheximide allows
translation on the polyribosomes to be completed
(Ramirez et al., 1991). Because new rounds of initiation are infrequent during cell harvest and extract
preparation, 80S ribosomes and the 40S and 60S
subunits accumulate at the expense of polyribosomes (Ramirez et al., 1991). The majority of the
ribosomal subunits were present in 80S particles as
judged by the A254 profile, but detectable amounts
of polyribosomes remained intact, as judged from
the A254 profile and the fact that 45% of Li was still
found in the fractions containing the polyribosomes
(14-24+P). Similar amounts of UPF1-3EP also extend into the polyribosome region of the gradient.
The amounts of UPF1-3EP and Li in fractions 1424+P were each reduced by about 20% compared
with extracts prepared in the presence of cycloheximide. The remainder of UPF1-3EP and Li was
Vol. 6, May 1995

detected in fractions 8-13, which contain the 40S
and 60S ribosomal subunits and the 80S ribosomal
particles. In the absence of cycloheximide, very little
UPF1-3EP or Li was observed in fractions near the
top of gradient. Thus, UPF1-3EP and Li have very
similar distributions.
Cell extracts isolated in the presence or absence of
cycloheximide (Figure 5, C and D) were treated with
0.5 mg/ml RNase A before fractionation to disrupt the
polyribosomes. Using these conditions the majority of
the ribosomes were present in 80S particles as judged
by the A254 profile. Western blots show that the majority of Li accumulates at a position coincident with
the 80S particles. Only 15-20% of Li migrates in the
polyribosome region (fractions 14-24+P). Similarly,
only about 10% of UPF1-3EP migrated into this region
of the gradient. Two separate regions of peak accumulation were observed for UPF1-3EP. One corresponds
to monomers, small aggregates, and complexes (about
55% in fractions 1-7 irrespective of the presence or
absence of cycloheximide). The other peak location
was coincident with the 40S and 60S ribosomal subunits and the 80S ribosomal particle (about 35% in
fractions 8-13 irrespective of the presence or absence
of cycloheximide). Overall, RNase A treatment results
in a 65-85% reduction in the amount of UPF1-3EP
and Li found in fractions where polyribosomes migrate. A commensurate increase in accumulation of
these proteins was observed in fractions containing
monomers, smaller molecular weight aggregates and
complexes, 40S and 60S ribosomal subunits, and 80S
ribosomal particles.
Growth conditions affect the relative ratio of 80S
ribosomal particles to polyribosomes. Cells grown in
-Trp synthetic medium were shifted to YEPD medium for two cell generations before extraction in the
presence of 50 jig/ml cycloheximide (Figure 5E; MATERIALS AND METHODS). Under these nonselective
conditions, 75% of the cells retained the plasmid carrying UPF1-3EP. Polyribosomes accumulate at the expense of 80S ribosomal particles as judged by the A254
profile and the distribution of Li. About 80% of the Li
was detected in the polyribosome fractions
(14-24+P), whereas 75% of UPF1-3EP was detected in
these fractions. Growth in YEPD results in a 30% and
a 20% increase in the amounts of Li and UPF1-3EP,
respectively, in polyribosome fractions compared with
growth in -Trp synthetic medium. Approximately 5%
of UPF1-3EP was found in fractions 1-7 where monomers and small complexes migrate and 20% in fractions 8-13 where the 40S and 60S ribosomal subunits
and 80S ribosomal particles migrate. Compared with
Figure 5A, these results demonstrate that UPF1-3EP
and Li exhibit a similar shift in distribution in the
polyribosome region when cells are grown in medium
that supports rapid growth.
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Figure 5 cont. Strain PLY102 (Table 1) was transformed with
pRS314UPF1-3EP and grown in -Trp synthetic medium (MATERIALS AND METHODS). Cell extracts were separated on 7-47%
sucrose gradients as follows: in the (A) presence of 50 ,ug/ml
cycloheximide, in the (B) absence of cycloheximide, after treatment
with RNase A following isolation in the (C) presence of 50 ,ug/ml
cycloheximide or in the (D) absence of cycloheximide, and (E)
prepared from cells shifted to YEPD for two cell generations before
harvest in the presence of 50 ,ug/ml cycloheximide. Approximately
75% of the cells shifted to YEPD contained the plasmid at harvest
(see MATERIALS AND METHODS). The gradients were monitored
by absorbance at A2M4. Fractions taken from the gradients were
resolved on 10% polyacrylamide SDS gels. Westem blots prepared
from the gels were sequentially labeled with antibodies to detect
UPF1-3EP and LI using the ECL Westem blotting detection system
(Amersham). The distribution of UPF1-3EP and LI was determined
by quantitation of autoradiographs of Westem blots using a computing densitometer (see MATERIALS AND METHODS). The the
amounts of UPF1-3EP and LI in each fraction are shown with white
and black bars, respectively. Solubilized pellets from the sucrose
gradients (P) were included on the right of each panel. The positions
of 40S and 60S ribosomal subunits, 80S ribosomal particles, and
polyribosomes are also indicated.

Based on the changes in distribution observed for
UPF1-3EP and LI using three different sets of conditions that alter the polyribosome profile, we suggest
that UPF1-3EP associates with polyribosomes.
The Relative Abundance of UPF1
Given the evidence that UPF1-3EP associates with
polyribosomes, we wanted to estimate the
ribosome/UPF1 molar ratio. Because no tools are
Vol. 6, May 1995

yet available to determine the ratio at the protein
level, we measured the accumulation of UPF1
mRNA relative to the accumulation of ribosomal
protein S3 and L3 mRNA. S3, a component of the
40S ribosomal subunit, is encoded by the SUF14
gene (Hendrick and Culbertson, unpublished data).
L3, a component of the 60S subunit, is encoded by
the TCM1 gene (Fried and Warner, 1981). In yeast,
ribosomal protein gene expression is coordinately
controlled to ensure equimolar accumulation (reviewed in Woolford and Warner, 1991). Because
coordinate control is predominantly transcriptional,
we expect that the accumulation of mRNAs encoding different ribosomal proteins will be roughly
equivalent and proportional to the accumulation of
40S and 60S ribosomal subunits and 80S ribosomes.
Assuming that the mRNAs are all translated at similar rates, the relative ratios of UPF1, S3, and L3
mRNA should give an indication of UPF1 abundance relative to ribosomes.
To compare levels of mRNA accumulation, total
RNA extracted from strain PLY22 (Table 1) during
early, middle, and late logarithmic growth was probed
by Northern blotting. PLY22 carries the intron-less
UPF1, SUF14, and TCM1 genes in single copy at their
normal chromosomal locations. The length and G+C
content of uniformly labeled DNA probes from the
coding regions of each gene were as follows: UPF,
2305-bp, 39.5% G+C; SUF14, 652-bp, 44.0% G+C;
TCM1, 1097-bp, 43.8% G+C. The amount of radioactivity detected in the DNA/RNA hybrids, which corresponded to visible bands detected by autoradiography, was adjusted for probe length as described in
Table 2. The effects of small differences in G+C content were considered negligible.
The results of Northern blotting indicate that UPF1
mRNA is much less abundant than S3 or L3 mRNA
(Table 2). The average accumulation ratios for
S3/UPF1 and L3/UPF1 mRNA are approximately 120
and 90, respectively. The S3/L3 mRNA ratio was 1.3,
close to a theoretically expected ratio of 1.0. These
results indicate that UPF1 mRNA accumulates at a
much lower level than two ribosomal protein mRNAs.
On this basis, we suggest that the UPF1 protein may
be relatively nonabundant compared with ribosomes.
DISCUSSION
UPF1 Is Located Primarily in the Cytoplasm
We anticipated that UPF1 might be located in one or
more of several different intracellular compartments,
including the cytoplasm, the nucleus, or the mitochondrion.
A cytoplasmic location was suggested by evidence
that nonsense mRNAs subject to UPFl-mediated decay are found in polyribosomes, which are primarily
621
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Table 2. Relative abundance of UPF1 mRNAa

mRNA accumulation ratiob
Growth phase

Early log
Mid-log
Late log

OD600

S3/UPF1

L3/UPF1

S3/L3

0.27-0.30
0.51-0.54
1.5-1.6

118.3 (11.6)
118.9 (11.7)
123.5 (12.7)

93.8 (7.8)
88.0 (9.9)
87.7 (10.1)

1.3 (0.04)
1.3 (0.04)
1.4 (0.04)

aTotal RNA extracted from yeast strain PLY22 (Table 1) was analyzed by Northern blotting using the following uniformly labeled
DNA probes: 2305 bp from the coding region of UPF1; 652 bp from
the coding region of SUP14 (encoding ribosomal protein S3); 1097
bp from the coding region of TCM1 (encoding ribosomal protein
L3). The G+C content of each probe is 39.5, 44, and 43.8%, respectively.
bRatios were calculated using the adjusted CPM detected for each
DNA/RNA hybrid. Each ratio represents the average value for four
experiments. The standard deviation is shown in parentheses. The
adjusted CPM was calculated using the formula (absolute CPM
[minus] background)/probe length in kb). In each case the CPM
detected above background using the Betascope blot analyzer corresponds to visible bands detected by autoradiography of the
Northern blots. The limit of sensitivity for detection of radioactivity
by the Betascope in these experiments was calculated to be 0.5 CPM
above background (for five standard deviations).

cytoplasmic (Leeds et al., 1992). Furthermore, the nonsense mRNA decay pathway is triggered by premature translational termination, suggesting that translation, which is primarily a cytoplasmic event, plays a
role in decay.
A nuclear location either for UPF1 or the decay
pathway itself was also considered possible. UPF1
could influence the rate of nonsense mRNA decay
indirectly by affecting ribosome structure from a location in the nucleolus where ribosomal subunits are
assembled. Furthermore, recent studies in mammals
have led to the suggestion that nonsense mRNA decay
may be initiated by translation of nonsense mRNAs
that are still in the process of being transported from
the nucleus to the cytoplasm (Belgrader et al., 1993,
1994; Cheng and Maquat, 1993).
A role for UPF1 in the mitochondrion was suggested
by results showing that over-expression of UPF1 from
a multi-copy plasmid suppresses a mitochondrial
mRNA splicing defect (Ben Asher et al., 1989; Altamura et al., 1992). Also, loss of UPF1 function confers
a reduced rate of growth in medium containing lactate
as a sole carbon source, suggesting a requirement for
UPF1 in respiratory processes that occur in the mitochondria.
To find out where UPF1 is located, we placed a
DNA fragment coding for three copies of an influenza
HA epitope in frame at the 3' end of the UPF1 ORF.
Detection of the tagged product UPF1-3EP was
achieved using commercially available 12CA5 monoclonal antibodies. We had previously found that a
622

single copy of the same epitope placed at the same
position in UPF1 provided an insufficient signal. It
was visible on Western blots only when the singlytagged protein was overproduced. We also found an
unacceptable level of cross-reaction with an endogenous yeast protein that has an apparent molecular
weight of 51 k both by Western blotting and by immunofluorescent microscopy.
All of the problems with the single-epitope tagging
system were avoided using the triple-epitope.
UPF1-3EP was detected in protein extracts from a
strain carrying one copy of UPF1-3EP on a centromeric plasmid. No significant cross-reaction was evident by Western blotting, immunofluorescent microscopy, or confocal microscopy. Furthermore, tagging
the C-terminus provided another advantage by minimizing the chance of detecting incomplete, nascent
UPF1-3EP polypeptides on polyribosomes. Nascent
UPF1-3EP is released from polyribosomes soon after
synthesis of the C-terminal epitopes. Any epitopes
detected in association with polyribosomes are therefore likely to be located on full length UPF1-3EP protein molecules that have re-associated with polyribosomes.
The validity of our results depends on whether
UPF1-3EP retains its function despite the addition of
37 amino acids to the C-terminus. We assayed
UPF1-3EP function in strains lacking the normal UPF1
protein using three criteria: (1) the ability to suppress
growth in an allo-frameshift suppression assay (Figure
1; Culbertson et al., 1980), (2) the ability to restore
growth in medium containing lactate as the sole carbon source (Figure 4; Altamura et al., 1992) and, (3) the
ability to reduce steady-state accumulation of his4-38
mRNA through accelerated decay (Leeds et al., 1991).
Our results show that UPF1-3EP is 86% (± 5%) as
efficient as the wild-type UPF1 protein in promoting
nonsense mRNA decay. This modest reduction in
function is recessive. Because UPF1-3EP is functional,
we assume that its cellular location is identical to
wild-type UPF1.
Our results indicate that all of the detectable
UPF1-3EP is found in the cytoplasm. We could not
detect any UPF-3EP in the nucleus using three different approaches. UPFl-specific fluorescent antibody
staining was absent in the region of the nucleus that
stains with DAPI. Little overlap in differential fluorescent staining was detected when cells were double
labeled with fluorescent antibodies that recognize
UPF1-3EP and SEN1::,gal fusion protein that is distributed exclusively in the nucleoplasm. Finally, in
cells double labeled with antibodies that recognize
UPF1-3EP and the ER protein KAR2, no
UPFl-3EP-specific fluorescence was observed inside
the boundary of the nuclear envelope that is outlined
by KAR2 staining in 80% of cells. Considering the
strength of the cytoplasmic fluorescent signal obMolecular Biology of the Cell

Localization of UPF1

served using the triple epitope tag, the evidence favors
the view that the vast majority of UPF1-3EP is in the
cytoplasm. Nonetheless, there could be a minor fraction of nuclear or nucleolar UPF1-3EP that is present
at a concentration below the detection limits or that is
refractory to antibody staining.
Cytochemical studies comparing the location of
UPF1-3EP with the mitochondrial protein MAS2 suggest that there is little overlap in the distribution of
these two proteins. The possible presence of some
UPF1-3EP in the mitochondrion was further tested
using a cellular fractionation procedure that separates
mitochondria from other cellular components. A small
amount of UPF1-3EP was detected in the mitochondrial fraction, but it was proteinase K sensitive and
therefore located outside the mitochondria. The effects
of UPF1 on mitochondrial mRNA splicing, which
takes place inside the organelle, is therefore likely to
be an indirect consequence of UPF1 function. UPF1
may affect the level of expression of a yet to be identified nuclear gene whose product is required for mitochondrial function. This view is plausible because it
has already been shown that UPF1 affects the expression of some natural mRNAs (Leeds et al., 1991).
UPF1 Associates with Polyribosomes
We assessed the potential association of UPF1 with
polyribosomes by examining the behavior of
UPF1-3EP and ribosomal protein Li in sucrose gradients. The distribution of both proteins exhibited similar changes using three different sets of conditions
that alter the polyribosome profile. When cycloheximide was omitted, about 20% of both UPF1-3EP and
LI shifted out of fractions containing polyribosomes
and into fractions containing 80S ribosomal particles.
When preparations were treated with RNase A, 6585% of both UPF1-3EP and LI shifted from the polyribosomes to the fractions containing 80S ribosomal particles. Finally, when cells were shifted from a synthetic
to a rich medium that supports more rapid growth,
20-30% of both UPF1-3EP and Li shifted into fractions containing polyribosomes. UPF1-3EP and Li
may exhibit a similar shift due to an association of
UPF1 with polyribosomes. Further experiments will
be required to establish the molecular basis of the
proposed association.
A variable proportion of UPF1-3EP was detected in
fractions that do not contain ribosomal subunits, 80S
ribosomal particles, or polyribosomes. In the presence
of 50 ,ug/ml cycloheximide, about 20% of UPF1-3EP
was found in fractions containing monomers, small
aggregates, or small complexes. Less than 1% was
found in these fractions when cycloheximide was
omitted. RNase A treatment in the presence or absence
of cycloheximide also caused up to 50% of UPF1-3EP
to shift from the polyribosome fractions to the riboVol. 6, May 1995

some-free fractions. Combined with the observation
that complete loss of UPF1 function confers cycloheximide hypersensitivity (Leeds et al., 1992), we are considering the possibility that cycloheximide may inhibit
the association of UPF1-3EP with polyribosomes either indirectly or by direct competition for a binding
site on the 60S ribosomal subunit.
Yeast translational initiation factors, such as GCN2
(Ramirez et al., 1991), behave in sucrose gradients as
though they interact with ribosomes during translational initiation. GCN2 preferentially associates with
60S ribosomal subunits, 80S ribosomal particles, and
polyribosomes during exponential growth and it cosediments with 40S and 60S ribosomal subunits when
polyribosomes are disaggregated. These results suggest that GCN2 interacts with ribosomes during the
translation initiation cycle (Ramirez et al., 1991). By
contrast, UPF1 may associate with polyribosomes after formation of an initiation complex. UPF1-3EP accumulates in fractions containing 80S ribosomal particles and polyribosomes, but not in fractions
containing the 40S and 60S ribosomal subunits during
exponential growth. When polyribosomes are disaggregated, UPF1-3EP co-sediments with 80S ribosomal
particles, but does not appear to accumulate in fractions containing 40S or 60S ribosomal subunits.
UPF1-3EP therefore behaves more like a translational
elongation or termination factor.
Like other known translation factors that utilize
GTP hydrolysis to dissociate from polyribosomes,
UPF1 contains a consensus motif for GTP binding that
has the potential to control cyclic binding and release
of UPF1 from polyribosomes. It is generally thought
that conformational differences between GDP- and
GTP-bound forms of the translation factors influence
the relative rates of association and dissociation of the
factors from ribosomes. However, even if UPF1 binds
GTP for a similar purpose, it differs from other known
G-proteins that function in translation in that it is not
required to support normal cell growth and therefore
does not perform a function in protein synthesis that is
essential for growth (Leeds et al., 1991).
Functional Relationships between UPF1,
Polyribosomes, and Nonsense mRNA Decay
Although UPF1 function has been shown to be required in order for nonsense mRNA decay to occur, it
has not yet been established that it plays a direct role
in the decay pathway. Genetic evidence suggesting
that a direct role is possible comes primarily from the
analysis of both recessive and dominant mutations in
UPF1.
Leeds et al. (1992) reported that the phenotypes of
dominant point mutations in UPF1 resemble the phenotype of a recessive gene disruption that confers
complete loss of function. Both types of alleles result
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in the stabilization of nonsense mRNAs. The strength
of the dominant phenotype was found to depend on
the dosage of the dominant allele relative to the wildtype allele (Leeds et al., 1992). Nonsense mRNA decay
was inhibited to a greater extent when a dominant
allele was over-expressed relative to the wild-type
allele. Dominant UPF1 mutations meet all of the criteria of the classical dominant-negative phenotype. A
dominant-negative UPF1 protein might interfere with
wild-type UPF1 function by one of two general mechanisms (Herskowitz, 1987). It could act as a poison
subunit by forming a nonfunctional multimer with
wild-type UPF1 or with other proteins that interact
with UPF1. Alternatively, it could bind a substrate of
UPF1 more tightly than wild type and block UPF1
function by preventing access to a substrate.
Dominant-negative UPF1 mutations map exclusively within a conserved sequence motif (Leeds et al.,
1992) that shares similarity with proteins that have
helicase and/or RNA-dependent NTPase activity
(Koonin, 1993). The identification of dominant-negative mutations exclusively in this region suggests the
presence of a functional domain in UPF1 that has the
potential to interact with RNA, and that this interaction is important in the underlying mechanism for the
dominant-negative phenotype. The identity of the
proposed RNA could provide a way to determine
whether UPF1 performs a catalytic function in the
nonsense mRNA decay pathway.
In the absence of more direct information regarding UPF1 function, we cannot definitively infer
whether it associates with polyribosomes for the
purpose of catalyzing a step in the nonsense mRNA
decay pathway or whether it associates with polyribosomes to perform a function in translation that
indirectly promotes nonsense mRNA decay. What is
known is that the mRNA substrate for decay as well
as UPF1, a potential catalyst of a step in the decay
pathway, are both associated with polyribosomes
(Leeds et al., 1991). Given the uncertainty regarding
UPF1 function, our finding that UPF1 is primarily
cytoplasmic may not necessarily mean that nonsense mRNA decay is a cytoplasmic event. It remains possible that this type of decay occurs at the
interface of the nucleus and cytoplasm as proposed
by Belgrader et al. (1994).
Northern blotting was used as an indirect way to
measure the relative abundance of UPF1 to ribosomes.
After controlling as much as possible for differences in
hybridization efficiency, we found that ribosomal protein S3 and L3 mRNA accumulation was about 100fold lower. Furthermore, the codon bias index of 0.21
for UPF1 (Leeds et al., 1992) is typical of genes expressed at a low level, whereas the codon bias indices
for S3 and L3 (0.93 and 0.88, respectively) are typical of
yeast genes expressed at a high level (Bennetzen and
Hall, 1982). Even assuming that the rates of translation
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of the three genes are similar, the possibility of 1:1
ratio of UPF1 to ribosomes seems unlikely. The evidence to date suggests that there are far fewer UPF1
molecules than ribosomes per cell.
If UPF1 associates with polyribosomes to promote
nonsense mRNA decay, it remains to be explained
how those polyribosomes containing target mRNAs
could be identified by UPF1 fast enough to affect the
decay rate given the apparent low abundance of UPF1
relative to ribosomes. Some target mRNAs, such as
his4-38 mRNA, have a half-life of 3-4 min (Leeds et
al., 1991), which indicates that the time interval may be
too short for a relatively small number of UPF1 protein molecules to randomly scan polyribosomes for
the presence of target mRNAs. This raises two possibilities. Polyribosomes or target mRNAs may be
tagged in some way that allows for selective recognition, similar in principle to the way that proteins are
tagged for degradation by ubiquitin. Alternatively,
UPF1 may act downstream in the decay pathway and
might require the presence of other, perhaps more
abundant, proteins that associate with polyribosomes
or target mRNAs first. Experiments designed to distinguish between these alternatives are currently in
progress.
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